1. Home
  2. MIST vs FEIM Comparison

MIST vs FEIM Comparison

Compare MIST & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FEIM
  • Stock Information
  • Founded
  • MIST 2003
  • FEIM 1961
  • Country
  • MIST Canada
  • FEIM United States
  • Employees
  • MIST N/A
  • FEIM N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • MIST Health Care
  • FEIM Industrials
  • Exchange
  • MIST Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • MIST 81.5M
  • FEIM 119.5M
  • IPO Year
  • MIST N/A
  • FEIM N/A
  • Fundamental
  • Price
  • MIST $1.43
  • FEIM $12.80
  • Analyst Decision
  • MIST Strong Buy
  • FEIM
  • Analyst Count
  • MIST 3
  • FEIM 0
  • Target Price
  • MIST $13.00
  • FEIM N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • FEIM 19.0K
  • Earning Date
  • MIST 11-11-2024
  • FEIM 12-10-2024
  • Dividend Yield
  • MIST N/A
  • FEIM 7.98%
  • EPS Growth
  • MIST N/A
  • FEIM N/A
  • EPS
  • MIST N/A
  • FEIM 0.62
  • Revenue
  • MIST N/A
  • FEIM $57,943,000.00
  • Revenue This Year
  • MIST N/A
  • FEIM N/A
  • Revenue Next Year
  • MIST N/A
  • FEIM N/A
  • P/E Ratio
  • MIST N/A
  • FEIM $20.24
  • Revenue Growth
  • MIST N/A
  • FEIM 28.82
  • 52 Week Low
  • MIST $1.12
  • FEIM $7.20
  • 52 Week High
  • MIST $3.52
  • FEIM $14.50
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • FEIM 52.77
  • Support Level
  • MIST $1.41
  • FEIM $12.17
  • Resistance Level
  • MIST $1.53
  • FEIM $12.72
  • Average True Range (ATR)
  • MIST 0.07
  • FEIM 0.37
  • MACD
  • MIST -0.01
  • FEIM 0.01
  • Stochastic Oscillator
  • MIST 26.96
  • FEIM 45.37

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: